chr2-238170635-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_030768.3(ILKAP):c.1080C>T(p.Asp360Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00556 in 1,601,756 control chromosomes in the GnomAD database, including 122 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.014 ( 43 hom., cov: 33)
Exomes 𝑓: 0.0047 ( 79 hom. )
Consequence
ILKAP
NM_030768.3 synonymous
NM_030768.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.505
Genes affected
ILKAP (HGNC:15566): (ILK associated serine/threonine phosphatase) The protein encoded by this gene is a protein serine/threonine phosphatase of the PP2C family. This protein can interact with integrin-linked kinase (ILK/ILK1), a regulator of integrin mediated signaling, and regulate the kinase activity of ILK. Through the interaction with ILK, this protein may selectively affect the signaling process of ILK-mediated glycogen synthase kinase 3 beta (GSK3beta), and thus participate in Wnt signaling pathway. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BP6
Variant 2-238170635-G-A is Benign according to our data. Variant chr2-238170635-G-A is described in ClinVar as [Benign]. Clinvar id is 773568.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.505 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0141 (2146/152328) while in subpopulation AFR AF= 0.0425 (1768/41572). AF 95% confidence interval is 0.0409. There are 43 homozygotes in gnomad4. There are 1014 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 2146 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ILKAP | NM_030768.3 | c.1080C>T | p.Asp360Asp | synonymous_variant | 12/12 | ENST00000254654.8 | NP_110395.1 | |
ILKAP | XM_006712784.2 | c.876C>T | p.Asp292Asp | synonymous_variant | 11/11 | XP_006712847.1 | ||
ILKAP | XM_017005057.2 | c.720C>T | p.Asp240Asp | synonymous_variant | 9/9 | XP_016860546.1 | ||
ILKAP | XM_017005058.2 | c.684C>T | p.Asp228Asp | synonymous_variant | 8/8 | XP_016860547.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0141 AC: 2140AN: 152210Hom.: 42 Cov.: 33
GnomAD3 genomes
AF:
AC:
2140
AN:
152210
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00654 AC: 1629AN: 249132Hom.: 24 AF XY: 0.00631 AC XY: 850AN XY: 134786
GnomAD3 exomes
AF:
AC:
1629
AN:
249132
Hom.:
AF XY:
AC XY:
850
AN XY:
134786
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00466 AC: 6759AN: 1449428Hom.: 79 Cov.: 31 AF XY: 0.00486 AC XY: 3492AN XY: 718304
GnomAD4 exome
AF:
AC:
6759
AN:
1449428
Hom.:
Cov.:
31
AF XY:
AC XY:
3492
AN XY:
718304
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0141 AC: 2146AN: 152328Hom.: 43 Cov.: 33 AF XY: 0.0136 AC XY: 1014AN XY: 74492
GnomAD4 genome
AF:
AC:
2146
AN:
152328
Hom.:
Cov.:
33
AF XY:
AC XY:
1014
AN XY:
74492
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
21
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 26, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at